The apoproteins of pulmonary surfactant (PSAP) are thought to be critical for normal surfactant function. They bind to surfactant phospholipids and enhance their ability to form surface ifims in vitro. These acidic glycoproteins have monomeric molecular weights of 36,000, 32,000, and 28,000 . Each member of this family of proteins has a similar amino acid composition and their differences in electrophoretic mobility are due in part to glycosylation. We have derived the full amino acid sequence of PSAP-32 from the nucleotide sequence of PSAP cDNA. A cDNA library was prepared from canine lung poly(A)+ RNA and screened with oligonucleotide probes that were based on the NH2-terminal amino acids of PSAP-32 determined by Edman degradation. This protein has the striking feature of collagen-like and non-collagen-like sequences in the same polypeptide chain. There are 24 Gly-Xaa-Yaa triplets, where Yaa is often hydroxyproline. These repeats comprise one-third of PSAP near the NH2 terminus. The remaining two-thirds of PSAP is resistant to bacterial collagenase digestion and contains a possible N-glycosylation site near the carboxyl terminus. The NH2-terminal one-third of PSAP-32 probably contains the cysteine involved in interchain disulflde bonds.
PSAP-32 from the nucleotide sequence of PSAP cDNA. A cDNA library was prepared from canine lung poly(A)+ RNA and screened with oligonucleotide probes that were based on the NH2-terminal amino acids of PSAP-32 determined by Edman degradation. This protein has the striking feature of collagen-like and non-collagen-like sequences in the same polypeptide chain. There are 24 Gly-Xaa-Yaa triplets, where Yaa is often hydroxyproline. These repeats comprise one-third of PSAP near the NH2 terminus. The remaining two-thirds of PSAP is resistant to bacterial collagenase digestion and contains a possible N-glycosylation site near the carboxyl terminus. The NH2-terminal one-third of PSAP-32 probably contains the cysteine involved in interchain disulflde bonds.
Lung surfactant is a mixture of lipids and proteins in part responsible for the maintenance of alveolar stability by lowering the surface tension at the air-liquid interface (1). To decrease the interfacial tension, lung surfactant must be able to rapidly form a surface film. Previously, King and Clements (2) demonstrated that protein-depleted canine surfactant lipids formed surface films more slowly than the intact surfactant containing about 10% protein. They showed that two proteins (Mr 34,000 and 10,000) in canine lung surfactant were lung-specific (3) . While the smaller of these proteins has not been extensively investigated, acidic glycoproteins of Mr 28,000-40,000 have been identified in the lung surfactant from several species (4) (5) (6) (7) (8) (9) (10) (11) .
The ability of isolated canine surfactant proteins of Mr 28,000-40,000 to enhance the rate of surface film formation in vitro has been investigated. These proteins readily associate with synthetic phospholipids (12) and extracted surfactant lipids (13, 14) and in the presence of calcium ions promote extremely rapid formation of phospholipid surface films (14) . Calcium ions are also required for the rapid spreading of native canine surfactant (13) . These results have suggested a critical role for pulmonary surfactaInt apoprotein (PSAP) in normal lung function.
Canine PSAP comprises a family of proteins of Mr 28,000, 32,000, and 36,000 (PSAP-28, -32, and -36) (15) . They have the same NH2-terminal amino acid, isoleucine, and have nearly identical amino acid compositions. All three contain large quantities of glycine (17 mol %) and proline (10 mol %). Approximately half of the prolines are hydroxylated. These proteins are variably glycosylated. Removal of the carbohydrate from PSAP-32 and PSAP-36 by endoglycosidase F digestion results in proteins that comigrate in polyacrylamide gels with PSAP-28, which is not glycosylated.
We have extended these studies on canine PSAP and report here the full amino acid sequence derived from the sequence of cDNA containing the coding region for PSAP. Most striking is the observation that the NH2-terminal one-third of the primary structure is collagen-like, containing 24 Gly-Xaa-Yaa triads; the remaining two-thirds of the molecule has a sequence unlike that of collagen.
MATERIALS AND METHODS
Isolation of PSAP. Lung surfactant was isolated from the bronchoalveolar lavage fluid of adult dogs of either sex (2) and the apoproteins were isolated according to Hawgood et al. (14) . Proteins were sized by comparison with known protein standards (Pharmacia) after NaDodSO4/PAGE in slab gels (16) and staining with Coomassie blue. After reduction and alkylation, the electrophoretically separated PSAP-28, -32, and -36 were eluted from the slab gels and their amino acid sequences were determined on a gas-phase microsequencer (Applied Biosystems, Foster City, CA). These methods were essentially those described by Hunkapiller et al. (17) (18) (19) . PSAPs were digested with bacterial collagenase (Worthington) for 16 hr at 37°C, using 1 ,ug of enzyme per 50 ,ug of PSAP. For microsequencing, the major collagenase-resistant peptide was eluted from slab gels as described above.
Isolation of Canine Lung Poly(A)+ RNA. Total RNA was isolated from an adult canine lung by the guanidinium isothiocyanate method (20) . Polyadenylylated RNA was obtained by affinity chromatography through oligo(dT)-cellulose (Collaborative Research, Waltham, MA) (21) .
Preparation of cDNA. Starting with 5 ,ug of poly(A)+ RNA, double-stranded cDNA was synthesized by use of successive reactions (22) . First-strand cDNA synthesis with oligo(dT) (P-L Biochemicals) plus avian myeloblastosis virus reverse transcriptase (Life Sciences, St. Petersburg, FL) was followed by second-strand synthesis with Escherichia coli DNA polymerase I Klenow fragment A (New England Biolabs) and then digestion with nuclease S1 (Bethesda Research Laboratories). Double-stranded cDNA larger than 300 base pairs Abbreviations: PSAP, pulmonary surfactant apoprotein; bp, base pair(s). TTo whom correspondence should be addressed at current address: California Biotechnology, Inc., 2450 Bayshore Frontage Road, Mountain View, CA 94043.
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Proc. Natl. Acad. Sci. USA 82 (1985) (bp) was purified by gel filtration through a column of Sepharose 4B (Pharmacia).
Short oligodeoxycytidylate tails were added to the cDNA by using calf thymus terminal deoxynucleotidyl transferase (P-L Biochemicals) (23) . The oligo(dC)-tailed cDNA was annealed with 2.5 ,ug of pBR322 DNA that had been cleaved with Pst I and tailed with oligo(dG) (New England Nuclear). The resulting hybrids were used to transform Escherichia coli MC1061 to tetracycline resistance by the CaCl2 procedure (24) .
Library Screening. Recombinant clones were selected on LB agar plates containing tetracycline at 12.5 Ag/ml. The library was plated onto nitrocellulose filters which served as masters for subsequent replicas (25) , which were screened by in situ hybridization with the 32P-labeled probes described below (26 (29) .
Colony Filter Hybridizations. Filters were baked for 2 hr at 80°C under vacuum and then washed for 4 hr at 68°C with shaking in a large volume of 3 x NaCl/Cit (lx is 0.15 M NaCl/5 mM sodium citrate, pH 7.5) containing 0.1% NaDodSO4. The filters were prehybridized in 6x NaCl/Cit/ 0.1% NaDodSO4/1 mM EDTA/0.1% Ficoll/0.1% polyvinylpyrrolidone/0.1% bovine serum albumin/0.05% sodium pyrophosphate at 42°C for 4 hr.
Duplicate filters were hybridized with 5 x 106 cpm of one of each 32P-labeled oligonucleotide probe per filter in 10 ml of a hybridization solution identical to the prehybridization solution. Filters were hybridized for 1 hr with probe 375 at 37°C or with probe 374 at 45°C. Then the probe 375 filter was allowed to cool slowly to 28°C, and the probe 374 filter, to 37°C. After 1 hr at the lower temperatures, the filters were washed in 6x NaCVICit/0.1% NaDodSO4/0.05% sodium pyrophosphate twice at room temperature and then for 2 min at 37°C and 45°C for probes 375 and 374, respectively. The maximum and minimum hybridization temperatures and the final washing temperatures were obtained from the empirical formula Td = 4(G+C) + 2(A+T) (30) . The hybridized filters were dried and autoradiographed on Kodak XAR film with Dupont Cronex intensifying screens.
Before filters were hybridized with nick-translated cDNA probes, they were prewashed as described above, then prehybridized for 4 hr at 42°C in 6x NaCl/Cit/50% formamide/0.5% NaDodSO4/0.02% Ficoll/0.02% polyvinylpyrrolidone/0.02% bovine serum albumin containing yeast RNA (50 ,ug/ml) and denatured, sheared salmon sperm DNA (50 ,ug/ml). (31) , using restriction fragments of cDNAs subcloned in the phage M13 vectors mp8 and mp9 (32) .
RESULTS AND DISCUSSION Isolation of PSAP. The reduced PSAPs have apparent molecular weights of 36,000, 32,000, and 28,000 (Fig. 1, lane  B) , whereas unreduced PSAPs migrate as apparent dimers of Mr 70,000, 64,000, and 56,000 (lane E). We were able to determine the sequence of the first 33 NH2-terminal amino acids ofPSAP-32 by microsequencing. It has been shown (33) that most probably PSAP-28, -32, and-36 have the same primary sequence with different posttranslational modifications. In addition, the first 4 amino acids of PSAP-28 and the first 14 amino acids ofPSAP-36 have been determined and are identical to PSAP-32. Further support for the same primary sequence among the three proteins comes from studies using monoclonal antibodies. In these studies monoclonal antibodies crossreact equally to the three PSAP components (unpublished observations).
Isolation and Characterization of PSAP cDNA Clones. The partial amino acid sequence derived for PSAP-32 was used to design degenerate oligonucleotide probes to screen the canine lung cDNA library. The probes synthesized correspond to two nonoverlapping regions of the PSAP-32 NH2-terminal sequence (Fig. 2a) . Amino acids 1-5 were covered by probe 375, and amino acids 7-11 were covered by probe 374.
Of the 200,000 clones contained in the canine lung cDNA library, 40,000 recombinants were plated onto nitrocellulose filters. Four replica filters were prepared from each master filter, so that each colony could be screened in duplicate with each of the probes. A colony was considered positive if it hybridized in duplicate with both probes 375 and 374. Of several potential positive clones, one (pDS-1) hybridized much more intensely with both probes than did other colonies. The 380-bp insert of pDS-1 was isolated by preparative agarose gel electrophoresis after cleavage of the plasmid DNA with restriction endonuclease Pst I. The purified insert was subcloned in the Pst I site of M13 mp8 for nucleotide sequence analysis by the dideoxy method. Sequence analysis confirmed that pDS-1 encodes a portion of canine PSAP (Fig.  2b) including a putative 17 amino acid signal peptide, 33 NH2-terminal amino acids found by direct peptide sequence analysis of canine PSAP (Fig. 2) , and 71 additional downstream amino acids.
The pDS-1 insert was used as a probe to rescreen one duplicate set of colony filters for clones containing additional portions of the canine PSAP coding sequences. Of the 40,000 clones rescreened with 32P-labeled pDS-1, 80 were further characterized by nucleotide sequence analysis. As shown in Fig. 2b , these additional clones contain PSAP sequences 3' to those contained by pDS-1, and the combined sequences of pDS-1, -4, and -31 comprise 832 nucleotides of canine PSAP mRNA sequence, including the entire 747-bp coding region and portions of the 5' and 3' untranslated regions.
Blot hybridization analysis of electrophoretically separated canine lung poly(A)+ RNA showed that 32P-labeled pDS-1 cDNA hybridized with a single 2200-nucleotide RNA species (data not shown). By analogy with the known sequence and structure of the very similar human PSAP mRNA (unpublished observations), the canine PSAP mRNA probably consists of a short (100-nucleotide) 5' untranslated region, the 747-nucleotide coding region, and a long (1300-nucleotide) 3' untranslated region.
Sequence of PSAP. The nucleotide sequence allowed prediction of the primary amino acid sequence of canine PSAP (Fig. 2a) . The most striking feature of the amino acid sequence is the series of Gly-Xaa-Yaa repeats in the aminoterminal third of the protein. This type of sequence is the hallmark of collagens and non-collagen proteins like Clq (34) that contain regions of collagen-like sequence. After the NH2-terminal, non-collagen-like sequence of 10 amino acids, there are 12 Gly-Xaa-Yaa triads. The continuity of the collagen-like sequence is broken by the insertion of an extra glycine at position 47. After this break the Gly-Xaa-Yaa triads continue for an additional 12 repeats ending at Pro-83. The collagen-like sequence is followed by 148 residues of non-collagen-like sequence that continues through to the carboxyl-terminal phenylalanine.
The combination of collagen and non-collagen-like sequences in the same protein suggested that the molecule might be susceptible to hydrolysis by bacterial collagenase, like Clq and acetyl cholinesterase. Hydrolysis of the PSAP triplet resulted in the generation of a peptide of Mr 22,000 when analyzed by NaDodSO4/PAGE. This collagenaseresistant peptide was electroeluted from a preparative slab gel and sequenced. The collagenase-resistant peptide has an NH2-terminal glycine, as would be expected after collagenase digestion. An additional 35 amino acids were directly sequenced. This sequence is identical to amino acid residues 78-112 derived from the cDNA sequence. In addition, we observed another collagenase-sensitive site near the carboxyl terminus. The resulting peptide (Gly-203 through Phe-231) covered the carboxyl-terminal region of PSAP and its sequence again confirmed the amino acid sequence derived from the cDNA sequence. Thus, we have directly sequenced 97 amino acids in 3 different regions of the 231-residue polypeptide chain of PSAP.
Amino acid analysis of PSAP predicted 10-11 hydroxyproline residues. From the Edman degradation sequences, 5 of these can be assigned to prolines at positions 13, 16, 19, 25 , and 80 of the deduced sequence. Assignment of the remaining 5-6 hydroxyprolines awaits further analysis. Inspection of the sequence predicts that all of the remaining hydroxyprolines can be accounted for in the colagen-like region.
PSAPs are glycoproteins (8, 33, 35) . Two possible Nglycosylation sites are present in the sequence of PSAP, at Asn-3 and Asn-190 (Fig. 2) . These sites are predicted by the consensus sequence of Asn-Xaa-(Ser/Thr). Based on the molar yields of recovered phenylthiohydantoin amino acids from the microsequencer it is highly unlikely that Asn-3 is glycosylated to any significant degree in PSAP-32.
There are five cysteine residues in canine PSAP. One (Cys-9) is very near the beginning of the Gly-Xaa-Yaa repeats of the collagen-like region. The other four are in the putative globular portion ofthe molecule. Results of collagenase digestion studies suggest that Cys-9 is involved in an interchain disulfide bond.
When PSAP is analyzed by NaDodSO4/PAGE without reduction of disulfides, PSAP migrates as a triple band at Mr 60,000-70,000. The molecular weights correspond to dimers of PSAP-28, -32, and-36. After collagenase digestion, the peptide migrates with an apparent Mr of 22,000-24,000 whether reduced or unreduced. If the interchain disulfide bridges were located in the collagenase-resistant portion of PSAP, the expected molecular weight of the peptide should be near 45,000-50,000 in the absence of reducing agents. These results are shown in Fig. 1 . The potential intrachain disulfide bridge pattern has yet to be determined.
A putative leader or signal peptide is indicated as residues -1to -17 in Fig. 2 . This leader peptide is apparently cleaved prior to isolation of PSAP-32 (also PSAP-28 and PSAP-36) from the alveoli, since the NH2 terminus for all three PSAPs is isoleucine as determined by automated Edman degradation. These data would seem to be in disagreement with the suggestion of Floros et al. (35) , who studied the in vitro translation products of human PSAP mRNA. They suggested that the leader sequence might not' be cleaved prior to secretion and could therefore be a region capable of interaction with surfactant phospholipids. Although this is an attractive hypothesis, our data for canine PSAP show that the leader peptide is removed and could not be a lipid-binding domain in the airspaces. We are currently investigating the mechanisms of PSAP-phospholipid interactions.
PSAP is a very unusual protein in that the sequence predicts both collagen-like and globular peptide domains. The serum protein Clq, whose structure and amino acid sequence have been characterized extensively (34), has a primary structure similar to the PSAP. Both proteins have a cysteine that appears to form an interchain disulfide bridge within a few amino acids of the beginning of the Gly-Xaa-Yaa repeats. Both Clq and PSAP have an interruption in the Gly-Xaa-Yaa repeating sequence near the middle of the collagen-like sequence. Reid (34) has suggested that this could cause a "bend" in the triple-helical stem of Clq. Although we have not directly confirmed that PSAP monomers associate to form triple-helical structures, there is some evidence for a triple helix. Two important requirements for formation of collagen-like triple helix-glycine in every third position and a high content of imino acids including hydroxyproline-are met in PSAP. In addition, the susceptibility of the collagen-like domain to cleavage by bacterial collagenase is suggestive of a triple-helical region in PSAP. Acetylcholinesterase, another protein with a similar structure of collagen-like and globular domains, is also thought to form a triple helix (36) .
An amino acid composition similar to that of PSAP has been reported for the predominant protein in lung lavage from patients with alveolar proteinosis (37). Bhattacharyya et al. (38) have described short regions of Gly-Xaa-Yaa repeats in this protein. However, there is no homology between the sequence of the canine PSAP and the published sequences of small segments of the alveolar proteinosis glycoprotein (37) . We have recently isolated an acidic glycoprotein (pI 4.5-5.3, Mr 32,000-35,000) from the lavage fluid of a patient diagnosed as having alveolar proteinosis. Microsequencer analysis (22 residues) indicates that this protein does not have the same NH2-terminal sequence as that reported by Lynn (37) but is very similar to the canine PSAP NH2-terminal sequence. In addition, the NH2-terminal sequence (residues 1-22) of this alveolar proteinosis protein is identical to thF human PSAP amino acid sequence derived from the nucleofrde sequence of the human PSAP gene and cDNA (unpublished data). The reasons for the discrepancies between the sequence published by Lynn (37) for the protein he isolated and the sequence of the human PSAP and the alveolar proteinosis protein we obtain are not clear.
In summary, we report here the full amino acid sequence of canine PSAP, confirmed by Edman degradation sequencing of about 40% of the molecule. The sequence predicts an unusual structure containing both collagen-like and globular domains in the same protein. It is highly polarized, with the collagen-like sequences in the amino-terminal half of the protein. It is also polarized in that the aromatic amino acids are all found in the carboxyl-terminal half of the protein. The collagen-like portion also contains the cysteine predicted to form interchain-disulfide-bonded PSAP dimers. It is quite likely that this portion of the molecule is involved in selfassociation, possibly through collagen-like triple helices. Although the mechanism for association of PSAP with lipids is still unknown, the availability of a primary sequence should greatly facilitate further investigations of the structure and functions of this protein in normal and abnormal states of the lung surfactant system. 
